Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Polyzois Makras

Showing results (61-70 of 123) with videos related to

Pageof 13
Sort By:
Hormones (Athens, Greece)|June 27, 2025
Diagnosis and management of hypoparathyroidism: recommendations of the working group of the Bone Section of the Hellenic Endocrine SocietyEvanthia Kassi, Fotini Adamidou, Maria P Yavropoulou, et al.
European Journal of Endocrinology|November 13, 2016
Expression of microRNAs that regulate bone turnover in the serum of postmenopausal women with low bone mass and vertebral fracturesMaria P Yavropoulou, Athanasios D Anastasilakis, Polyzois Makras, et al.
The Journal of Clinical Endocrinology and Metabolism|November 7, 2014
Rationale for the application of RANKL inhibition in the treatment of Langerhans cell histiocytosisPolyzois Makras, Maria Salagianni, Kyriakos Revelos, et al.
Journal of Sports Sciences|October 1, 2005
Effect of 4 weeks of basic military training on peripheral blood leucocytes and urinary excretion of catecholamines and cortisolPolyzois Makras, George N Koukoulis, George Bourikas, et al.
The Journal of Clinical Endocrinology and Metabolism|June 11, 2020
Serum Profile of microRNAs Linked to Bone Metabolism During Sequential Treatment for Postmenopausal OsteoporosisMaria P Yavropoulou, Athanasios D Anastasilakis, Polyzois Makras, et al.
Metabolism: Clinical and Experimental|May 24, 2020
Extra-skeletal effects of bisphosphonatesArgyro Panagiotakou, Maria Yavropoulou, Narjes Nasiri-Ansari, et al.
Metabolism: Clinical and Experimental|January 1, 2023
Activins, follistatins and inhibins in postmenopausal osteoporosis: A proof of concept, case-control studyAthanasios D Anastasilakis, Stergios A Polyzos, Nikolaos E Rodopaios, et al.
Metabolism: Clinical and Experimental|May 20, 2017
Low periostin levels in adult patients with Langerhans cell histiocytosis are independently associated with the disease activityAthanasios D Anastasilakis, Stergios A Polyzos, Marina Tsoli, et al.
Clinical Cases in Mineral and Bone Metabolism : the Official Journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases|December 22, 2017
Periostin and sclerostin levels in juvenile Paget's diseaseStergios A Polyzos, Polyzois Makras, Athanasios D Anastasilakis, et al.
The Journal of Clinical Endocrinology and Metabolism|April 13, 2026
Approach to the Patient: Management of bone fragility in patients with chronic hypoparathyroidismSymeon Tournis, Evanthia Kassi, Andrea Palermo, et al.
Pageof 13

Showing results (61-70 of 123) with videos related to

Sort By:
Pageof 13
Hormones (Athens, Greece)|June 27, 2025
Diagnosis and management of hypoparathyroidism: recommendations of the working group of the Bone Section of the Hellenic Endocrine SocietyEvanthia Kassi, Fotini Adamidou, Maria P Yavropoulou, et al.
European Journal of Endocrinology|November 13, 2016
Expression of microRNAs that regulate bone turnover in the serum of postmenopausal women with low bone mass and vertebral fracturesMaria P Yavropoulou, Athanasios D Anastasilakis, Polyzois Makras, et al.
The Journal of Clinical Endocrinology and Metabolism|November 7, 2014
Rationale for the application of RANKL inhibition in the treatment of Langerhans cell histiocytosisPolyzois Makras, Maria Salagianni, Kyriakos Revelos, et al.
Journal of Sports Sciences|October 1, 2005
Effect of 4 weeks of basic military training on peripheral blood leucocytes and urinary excretion of catecholamines and cortisolPolyzois Makras, George N Koukoulis, George Bourikas, et al.
The Journal of Clinical Endocrinology and Metabolism|June 11, 2020
Serum Profile of microRNAs Linked to Bone Metabolism During Sequential Treatment for Postmenopausal OsteoporosisMaria P Yavropoulou, Athanasios D Anastasilakis, Polyzois Makras, et al.
Metabolism: Clinical and Experimental|May 24, 2020
Extra-skeletal effects of bisphosphonatesArgyro Panagiotakou, Maria Yavropoulou, Narjes Nasiri-Ansari, et al.
Metabolism: Clinical and Experimental|January 1, 2023
Activins, follistatins and inhibins in postmenopausal osteoporosis: A proof of concept, case-control studyAthanasios D Anastasilakis, Stergios A Polyzos, Nikolaos E Rodopaios, et al.
Metabolism: Clinical and Experimental|May 20, 2017
Low periostin levels in adult patients with Langerhans cell histiocytosis are independently associated with the disease activityAthanasios D Anastasilakis, Stergios A Polyzos, Marina Tsoli, et al.
Clinical Cases in Mineral and Bone Metabolism : the Official Journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases|December 22, 2017
Periostin and sclerostin levels in juvenile Paget's diseaseStergios A Polyzos, Polyzois Makras, Athanasios D Anastasilakis, et al.
The Journal of Clinical Endocrinology and Metabolism|April 13, 2026
Approach to the Patient: Management of bone fragility in patients with chronic hypoparathyroidismSymeon Tournis, Evanthia Kassi, Andrea Palermo, et al.
Pageof 13